Gene · 58508
Papers4,204
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 4,204
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Association between human leukocyte antigen and immunosuppressive treatment outcomes in Chinese patients with aplastic anemia. | Front Immunol | 2023 | 36793734 | PubTator, text mining | PubMed |
| Studying the connection between SF3B1 and four types of cancer by analyzing networks constructed based on published research. | Sci Rep | 2023 | 36792691 | PubTator, text mining | PubMed |
| CD103 and CD39 coexpression identifies neoantigen-specific cytotoxic T cells in colorectal cancers with low mutation burden. | J Immunother Cancer | 2023 | 36792124 | PubTator, text mining | PubMed |
| A case report and literature review on nephrogenic alveolar soft part sarcoma: clinicopathological manifestations and genetic features. | BMC Urol | 2023 | 36782230 | PubTator, text mining | PubMed |
| Comparison of the mutation patterns between tumor tissue and cell-free DNA in stage IV gastric cancer. | Aging (Albany NY) | 2023 | 36779847 | PubTator, text mining | PubMed |
| Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma. | Cancer Res | 2023 | 36779841 | PubTator, text mining | PubMed |
| Molecular genetic and clinical characteristic analysis of primary signet ring cell carcinoma of urinary bladder identified by a novel OR2L5 mutation. | Cancer Med | 2023 | 36779496 | PubTator, text mining | PubMed |
| Recent Advances in Well-Designed Therapeutic Nanosystems for the Pancreatic Ductal Adenocarcinoma Treatment Dilemma. | Molecules | 2023 | 36771172 | PubTator, text mining | PubMed |
| Primary Liver Cancers: Connecting the Dots of Cellular Studies and Epidemiology with Metabolomics. | Int J Mol Sci | 2023 | 36768732 | PubTator, text mining | PubMed |
| Urinary Extracellular Vesicles in Chronic Kidney Disease: From Bench to Bedside? | Diagnostics (Basel) | 2023 | 36766548 | PubTator, text mining | PubMed |
| Genetics of Hepatocellular Carcinoma: From Tumor to Circulating DNA. | Cancers (Basel) | 2023 | 36765775 | PubTator, text mining | PubMed |
| Follicular Lymphoma in the 5th Edition of the WHO-Classification of Haematolymphoid Neoplasms-Updated Classification and New Biological Data. | Cancers (Basel) | 2023 | 36765742 | PubTator, text mining | PubMed |
| Genetics, Genomics and Emerging Molecular Therapies of Pancreatic Cancer. | Cancers (Basel) | 2023 | 36765737 | PubTator, text mining | PubMed |
| Advances in the Molecular Landscape of Lung Cancer Brain Metastasis. | Cancers (Basel) | 2023 | 36765679 | PubTator, text mining | PubMed |
| Loss of phosphatase CTDNEP1 potentiates aggressive medulloblastoma by triggering MYC amplification and genomic instability. | Nat Commun | 2023 | 36765089 | PubTator, text mining | PubMed |
| Progress and perspectives of perioperative immunotherapy in non-small cell lung cancer. | Front Oncol | 2023 | 36761954 | PubTator, text mining | PubMed |
| Identification of tumor antigens and immune landscapes for bladder urothelial carcinoma mRNA vaccine. | Front Immunol | 2023 | 36761744 | PubTator, text mining | PubMed |
| Research progress of neoantigen-based dendritic cell vaccines in pancreatic cancer. | Front Immunol | 2023 | 36761724 | PubTator, text mining | PubMed |
| Current therapeutic modalities and chemopreventive role of natural products in liver cancer: Progress and promise. | World J Hepatol | 2023 | 36744169 | PubTator, text mining | PubMed |
| Frequently mutated genes in predicting the relapse of stage I lung adenocarcinoma. | Clin Transl Oncol | 2023 | 36739576 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/58508/papers?page=40